Imaging and mapping of arrhythmias in hypertrophic cardiomyopathy

Mark S. Link, Christopher Phelan, Mohamed Aljaabari, N. A. Mark Estes

Research output: Chapter in Book/Report/Conference proceedingChapter


The most common sustained arrhythmia in hypertrophic cardiomyopathy, atrial fibrillation generally produces symptoms that impact quality of life and is associated with risk for embolic stroke. When antiarrhythmic agents fail to maintain normal sinus rhythm in symptomatic patients, catheter ablation is generally the next treatment option. With advances in mapping and ablation techniques, clinical outcomes with ablation have shown continued improvement. Catheter ablation has been used successfully in large series of patients with monomorphic ventricular tachycardia that occurs in the setting of ischemic, non-ischemic, congenital, and valvular heart disease. However, there is considerably less clinical data with imaging, mapping, and catheter ablation of ventricular arrhythmias in HCM. When antiarrhythmic therapy is not successful in treating AF, ablation using radiofrequency energy or cryoablation is a safe and generally successful approach. Less commonly, surgical treatment with a maze procedure is needed for pharmacologically refractory AF that has not responded to catheter ablation.

Original languageEnglish (US)
Title of host publicationCardiac Mapping
Number of pages11
ISBN (Electronic)9781119152637
ISBN (Print)9781119152590
StatePublished - Apr 5 2019


  • Antiarrhythmic agents
  • Atrial fibrillation
  • Catheter ablation
  • Embolic stroke
  • Hypertrophic cardiomyopathy
  • Mapping techniques
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Imaging and mapping of arrhythmias in hypertrophic cardiomyopathy'. Together they form a unique fingerprint.

Cite this